Verification evidence is still being completed.
PDF / print export
Medpace Germany
Munich, Germany
- Verified lead
- August J. Troendle
- Lead status
- STATUS: VERIFIED MARCH 2026
- Leadership verification
- Founder, Chairman and Chief Executive Officer
- 2026 technical specialization
- Clinical Development, Biostatistics, Pharmacovigilance, Regulatory Operations
- Review cycle
- May 2026
- Full address
- Theresienhoehe 30, 80339 Munchen, Germany
- Site coordinates
- Verification evidence is still being completed.
- Editorial review
- Memel Biotech editorial review
- Official leadership source
- Medpace Germany operating footprint.
- Editorial note
- Clinical-operations platform supporting sponsor execution, monitoring throughput, and multi-country study delivery from Germany.
Clinical Development, Biostatistics, Pharmacovigilance, Regulatory Operations
GxP-aligned clinical services platform, ICH-GCP operating controls
Clinical-operations platform supporting sponsor execution, monitoring throughput, and multi-country study delivery from Germany.
Review coverage
Leadership
Facility
Certifications
Capabilities
Partners
Sources
Quality
Editorial verificationMemel Biotech directory review sign-off
Report generated02 Jun 2026, 01:40
Clinical-operations platform supporting sponsor execution, monitoring throughput, and multi-country study delivery from Germany.
- Lead
- August J. Troendle (verified ↗)
- Address
- Theresienhoehe 30, 80339 Munchen, Germany (source ↗)
- Compliance
- GxP-aligned clinical services platform · ICH-GCP operating controls
- Last reviewed
- 14 Mar 2026 (3mo ago)
- Scale
- European clinical-services delivery
- Capabilities
- Clinical trial operations · Biostatistics and data management · Pharmacovigilance and medical monitoring
- Founded
- 1992
- Headcount
- 5001-10000
- Company page (open ↗)
Clinical profileSTATUS: VERIFIED MARCH 2026
August J. Troendle
Founder, Chairman and Chief Executive Officer
Full addressTheresienhoehe 30, 80339 Munchen, Germany
Site coordinatesVerification evidence is still being completed.
Review cycleMay 2026
Physical site source
Official Medpace locations page listing the Munich office at Theresienhoehe 30.
Open sourceEuropean clinical-services delivery
Munich, Germany. Clinical Development, Biostatistics, Pharmacovigilance, Regulatory Operations. Review completed on 14 Mar 2026.
EU clinical-trial, pharmacovigilance, and regulatory-services oversight
GxP-aligned clinical services platform, ICH-GCP operating controls
Clinical Development, Biostatistics, Pharmacovigilance, Regulatory Operations
Clinical-operations platform supporting sponsor execution, monitoring throughput, and multi-country study delivery from Germany.
Editorial note
Medpace publishes Germany as part of its European clinical-operations footprint. The registry records the current official chief executive together with the public Germany location disclosure rather than inventing a separate site-level CEO.
FULL TRUST REVIEW COMPLETE
Shown only when all seven trust checks are fully mapped in the directory.
Current review cycleMarch 2026
Capabilities
Core capabilities
Primary declared technical activities and areas of operating focus.
Clinical trial operations
Biostatistics and data management
Pharmacovigilance and medical monitoring
Regulatory strategy and submission support
Verification source dossier
Verification source dossier
Official source set used to support leadership, physical-site, certification, and watch-note evidence.
Infrastructure
Declared infrastructure
Clinical operations platform
Safety and pharmacovigilance workflows
Regulatory documentation systems
Regulatory posture
Quality system coverage
GMP / GLP / ISO-13485 / FDA-Inspected are global quality-system standards. "Verified active" means the directory confirmed the certification is current; "Review in progress" means the cert status is currently being re-verified.
- GMP
- REVIEW IN PROGRESS 2026
- GLP
- REVIEW IN PROGRESS 2026
- ISO-13485
- REVIEW IN PROGRESS 2026
- FDA-Inspected
- REVIEW IN PROGRESS 2026
Verification history
Verification history
14 Mar 2026: Executive identity confirmed via official management disclosure.
14 Mar 2026: Full trust review completed.
FAQ
Frequently asked questions
- Where is Medpace Germany located?
- Medpace Germany operates from Theresienhoehe 30, 80339 Munchen, Germany, Munich, Germany.
- Who runs Medpace Germany?
- Medpace Germany is led by August J. Troendle, Founder, Chairman and Chief Executive Officer. Verified 14 Mar 2026.
- What certifications does Medpace Germany hold?
- Medpace Germany is documented under GxP-aligned clinical services platform, ICH-GCP operating controls.
- What does Medpace Germany do?
- Clinical-operations platform supporting sponsor execution, monitoring throughput, and multi-country study delivery from Germany. Core capabilities: Clinical trial operations, Biostatistics and data management, Pharmacovigilance and medical monitoring, Regulatory strategy and submission support.
Editorial context
Related technical briefs
Briefs that name Munich as a covered market or city.